Heading back into CNS

Best known for its work in oncology and immunology, Genentech Inc. has decided to have another go at neurological diseases with last week's deal to license a preclinical antibody program for Alzheimer's disease from AC Immune Ltd.

Genentech (DNA, South San Francisco, Calif.) has done

Read the full 454 word article

User Sign In